CARRIE PETERSON: Open Payments
NPI 1881055291 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 12 payments from 8 companies in 2025. Trend: 2023 $304 · 2024 $436 · 2025 $763
Food & beverage: $676Education: $87
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 3 | $166 |
| Genmab U.S., Inc. | 1 | $120 |
| Incyte Corporation | 1 | $114 |
| Janssen Biotech, Inc. | 2 | $112 |
| GlaxoSmithKline, LLC. | 1 | $92 |
| Karyopharm Therapeutics Inc. | 1 | $91 |
| Celgene Corporation | 2 | $42 |
| PFIZER INC. | 1 | $25 |
Products named: Yescarta, Epkinly, Niktimvo, OJJAARA, XPOVIO, DARZALEX, CARVYKTI, ELREXFIO.
Industry payments across AZ — which companies pay providers there.
